Real-world data of zanubrutinib treatment for patients with previously treated Waldenstrom Macroglobulinemia

被引：0
|
作者：
Jang, Seo Yoon [1 ]
Kwon, Soyean [1 ]
Byun, Ja Min [1 ]
Koh, Youngil [1 ]
Hong, Junshik [1 ]
Yoon, Sung-Soo [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-429
引用
收藏
页码：S277 / S277
页数：1
相关论文
共 50 条
  • [41] A Real-World Study of Zanubrutinib Treatment in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Zhu, Huayuan
    Xia, Yi
    Miao, Yi
    Qin, Shuchao
    Wu, Wei
    Qiu, Tonglu
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2023, 142
  • [42] Real-world data from risdiplam treatment of SMA patients
    Palasti, A.
    Molnar, V.
    Ripszam, E.
    Toreki, N.
    Grosz, Z.
    Zsumbera, V.
    Udvari, S.
    Molnar, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 658 - 658
  • [43] Rituximab therapy in previously treated Waldenstrom's macroglobulinemia: Preliminary evidence of activity.
    Byrd, JC
    White, CA
    Link, B
    Thomas, S
    Valasquez, WS
    Rosenberg, J
    Grillo-Lopez, AJ
    BLOOD, 1998, 92 (10) : 106A - 106A
  • [44] Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia
    Treon, Steven P.
    Meid, Kirsten
    Gustine, Joshua
    Yang, Guang
    Xu, Lian
    Liu, Xia
    Patterson, Christopher J.
    Hunter, Zachary R.
    Branagan, Andrew R.
    Laubach, Jacob P.
    Ghobrial, Irene M.
    Palomba, M. Lia
    Advani, Ranjana
    Castillo, Jorge J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 565 - +
  • [45] Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study
    Alvarez, R.
    Carcereny, E.
    Padilla, A.
    Rodriguez Garcia, J. M.
    Cordoba, J. F.
    Esteban, E.
    Aguado, C.
    Garde, J.
    Moreno Vega, A.
    Avila Andrade, C.
    Sereno, M.
    Sanchez-Hernandez, A.
    Lopez-Brea, M.
    Massuti, B.
    Marti Blanco, C.
    Campayo, M.
    Arnaiz, P.
    Perez Parente, D.
    Fajardo, C. A.
    Ramos, I.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S625 - S626
  • [46] ASPEN: Results of a phase 3 randomized trial of zanubrutinib versus ibrutinib for patients with Waldenstrom Macroglobulinemia (WM)
    Buske, C.
    Dimopoulos, M.
    Opat, S.
    D'Sa, S.
    Jurczak, W.
    Lee, H-P
    Cull, G.
    Owen, R. G.
    Marlton, P.
    Wahlin, B. E.
    Garcia, Sanz R.
    McCarthy, H.
    Mulligan, S.
    Tedeschi, A.
    Castillo, J.
    Czyz, J.
    Fernandez De Larrea, C.
    Belada, D.
    Libby, E.
    Matous, J.
    Motta, M.
    Siddiqi, T.
    Tani, M.
    Trneny, M.
    Minnema, M.
    Leblond, V
    Chan, W. Y.
    Schneider, J.
    Cohen, A.
    Huang, J.
    Tam, C. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 107 - 108
  • [47] Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients
    Linardou, Helena
    Lampaki, Sofia
    Koliou, Georgia-Angeliki
    Vozikis, Athanassios
    Boutis, Anastasios
    Nikolaidi, Adamantia
    Kontogiorgos, Ioannis
    Papakotoulas, Pavlos
    Christopoulou, Athina
    Spyratos, Dionysios
    Bafaloukos, Dimitrios
    Psyrri, Amanda
    Grivas, Anastasios
    Koumarianou, Anna
    Tsiakitzis, Karyofyllis
    Mauri, Davide
    Rigakos, Georgios
    Aravantinos, Gerasimos
    Papantoniou, Panagiotis
    Oikonomopoulos, Georgios
    Fountzilas, Elena
    Koufaki, Margarita-ioanna
    Kaparelou, Maria
    Liolis, Elias
    Mountzios, Giannis
    Kosmidis, Paris
    Fountzilas, George
    Samantas, Epaminondas
    ANTICANCER RESEARCH, 2023, 43 (06) : 2799 - 2812
  • [48] ASPEN: Results of a phase III randomized trial of zanubrutinib versus ibrutinib for patients with Waldenstrom macroglobulinemia (WM).
    Tam, Constantine Si Lun
    Opat, Stephen
    D'Sa, Shirley
    Jurczak, Wojciech
    Lee, Hui-Peng
    Cull, Gavin
    Owen, Roger G.
    Marlton, Paula
    Wahlin, Bjorn E.
    Tedeschi, Alessandra
    Castillo, Jorge J.
    Siddiqi, Tanya
    Buske, Christian
    Leblond, Veronique
    Chan, Wai Y.
    Schneider, Jingjing
    Ro, Sunhee K.
    Cohen, Aileen
    Huang, Jane
    Dimopoulos, Meletios A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenstrom macroglobulinemia
    Tam, Constantine S.
    LeBlond, Veronique
    Novotny, William
    Owen, Roger G.
    Tedeschi, Alessandra
    Atwal, Siminder
    Cohen, Aileen
    Huang, Jane
    Buske, Christian
    FUTURE ONCOLOGY, 2018, 14 (22) : 2229 - 2237
  • [50] ASPEN: RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB VERSUS IBRUTINIB FOR PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA (WM)
    Tedeschi, A.
    Dimopoulos, M.
    Opat, S.
    D'Sa, S.
    Jurczak, W.
    Lee, H.
    Cull, G.
    Owen, R.
    Marlton, P.
    Wahlin, B.
    Garcia Sanz, R.
    McCarthy, H.
    Mulligan, S.
    Castillo, J.
    Czyz, J.
    Fernandez De Larrea, C.
    Belada, D.
    Libby, E.
    Matous, J.
    Motta, M.
    Siddiqi, T.
    Tani, M.
    Trneny, M.
    Minnema, M.
    Buske, C.
    Leblond, V.
    Chan, W.
    Schneider, J.
    Cohen, A.
    Huang, J.
    Tam, C.
    HAEMATOLOGICA, 2021, 106 (10) : 9 - 10
12345